Letter by Singh et al Regarding Article, "Effect of Empagliflozin on Left Ventricular Volumes in Patients With Type 2 Diabetes, or Prediabetes, and Heart Failure With Reduced Ejection Fraction (SUGAR-DM-HF)"

Affiliations

Comment

Jagdeep S Singh et al. Circulation. 2021.

. 2021 Jul 20;144(3):e38-e39.

doi: 10.1161/CIRCULATIONAHA.120.053057. Epub 2021 Jul 19.

¹ Division of Molecular and Clinical Medicine, University of Dundee Medical School, Scotland, United Kingdom.

No abstract available

Comment in

Response by Lee et al to Letter Regarding Article, "Effect of Empagliflozin on Left Ventricular Volumes in Patients With Type 2 Diabetes, or Prediabetes, and Heart Failure With Reduced Ejection Fraction (SUGAR-DM-HF)".
Lee MMY, McMurray JJV, Jhund PS, Petrie MC, Sattar N. Lee MMY, et al. Circulation. 2021 Jul 20;144(3):e40. doi: 10.1161/CIRCULATIONAHA.121.055067. Epub 2021 Jul 19. Circulation. 2021. PMID: 34279995 No abstract available.

Effect of Empagliflozin on Left Ventricular Volumes in Patients With Type 2 Diabetes, or Prediabetes, and Heart Failure With Reduced Ejection Fraction (SUGAR-DM-HF).
Lee MMY, Brooksbank KJM, Wetherall K, Mangion K, Roditi G, Campbell RT, Berry C, Chong V, Coyle L, Docherty KF, Dreisbach JG, Labinjoh C, Lang NN, Lennie V, McConnachie A, Murphy CL, Petrie CJ, Petrie JR, Speirits IA, Sourbron S, Welsh P, Woodward R, Radjenovic A, Mark PB, McMurray JJV, Jhund PS, Petrie MC, Sattar N. Lee MMY, et al. Circulation. 2021 Feb 9;143(6):516-525. doi: 10.1161/CIRCULATIONAHA.120.052186. Epub 2020 Nov 13. Circulation. 2021. PMID: 33186500 Free PMC article. Clinical Trial.